ArticleInternational journal of clinical pharmacy2017
Impact of a medication therapy management service on the clinical status of patients with chronic obstructive pulmonary disease.
Article in International journal of clinical pharmacy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.
- Effectiveness of Hospital Pharmacist Interventions for COPD Patients: A Systematic Literature Review and Logic Model.International journal of chronic obstructive pulmonary disease · 2022Pooled it
- Promoting Community Pharmacy Practice for Chronic Obstructive Pulmonary Disease (COPD) Management: A Systematic Review and Logic Model.International journal of chronic obstructive pulmonary disease · 2020Pooled it
- Assessment of drug therapy problems and associated factors among PLWHA and tuberculosis admitted to two referral hospitals in Lusaka, Zambia.BMC infectious diseases · 2026Observational
- Polypharmacy in Patients With COPD: A Scoping Review.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2025Article
- Acceptability and consumers' willingness to pay for comprehensive medication management services in Brazil.Journal of comparative effectiveness research · 2024Article
- Polypharmacy - is there a cure for drug therapy problems?Croatian medical journal · 2023Article
- Pharmacists' Knowledge, Attitude, and Practice of Medication Therapy Management: A Systematic Review.Healthcare (Basel, Switzerland) · 2022Review
- Pharmacists' knowledge and attitudes toward medication therapy management service and the associated challenges and barriers for its implementation.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022Article
- Community pharmacists on the frontline in the chronic disease management: The need for primary healthcare policy reforms in low and middle income countries.Exploratory research in clinical and social pharmacy · 2021Article
- Decision-Making Process in Comprehensive Medication Management Services: From the Understanding to the Development of a Theoretical Model.Pharmacy (Basel, Switzerland) · 2020Article
- Implementation of pharmaceutical care for older adults in the brazilian public health system: a case study and realistic evaluation.BMC health services research · 2020Article
- Drug therapy problems for patients with tuberculosis and HIV/AIDS at a reference hospital.Einstein (Sao Paulo, Brazil) · 2019Article
- Clinical Results of Comprehensive Medication Management Services in Primary Care in Belo Horizonte.Pharmacy (Basel, Switzerland) · 2019Article
- Evaluation of outcomes of medication therapy management (MTM) services for patients with chronic obstructive pulmonary disease (COPD).Pakistan journal of medical sciencesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background At this moment, there is no information in the literature showing the impact of comprehensive medication management (CMM) service delivered to patients with chronic obstructive pulmonary disease. Objective This study aims to present the clinical outcomes of this service provided to patients with chronic obstructive pulmonary disease. Settings Public specialty pharmacy where high cost drug treatments are provided for medical conditions not covered by the primary care such as COPD, located in Minas Gerais State, Brazil. Methods A retrospective analysis was conducted for 83 patients. The dependent variable in this study was the sum of the drug therapy problems detected during the first and second consultation. The independent variables were age, number of diseases and medications, diagnosis of hypertension, dyslipidemia and diabetes, and tabagism. Univariate and multivariate analyses were performed using Pearson's Chisquare test. A level of significance of 5% was adopted for all analyses. Main outcomes Number, types and proportion of resolved drug therapy problems. Results Two hundred seventy seven drug therapy problems were identified, of which 53.1% were resolved. The most frequent drug therapy problem was the "use of unnecessary drug therapy" (n = 55; 19.8%). The identification of three or more drug therapy problem was higher among patients using five medications or more and among those using ten or more (p < 0.05). After the delivery of medication therapy management, the proportion of patients presenting "stable" clinical status was raised from 27 to 54% (p = 0.001). Conclusion CMM service demonstrates a positive impact on clinical outcomes of patients with chronic obstructive pulmonary disease and should prioritize patients with polypharmacy because they might have a higher number of drug therapy problems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.